by MaxGanik | Jul 30, 2014 | Blog, Finance & Economics, Today's News
Posted July 30, 2014 9:09pm After last night’s earnings report, I am assessing whether or not to buy the 20% pop in TWTR shares. After looking over the numbers, I think TWTR is a buy for a number of reasons. First, they beat on every metric: earnings, users, revenue,...
by MaxGanik | Jun 30, 2014 | Blog, Finance & Economics
Posted June 30, 2014 10:10pm With SPY premiums so low, one could make the argument that it is smartest to buy premium outright. That means, do not sell anything against the long calls or puts. The problem with this is that the market is just not moving. The volatility...
by MaxGanik | May 31, 2014 | Blog, Finance & Economics
Posted May 31, 2014 8:18pm Right now, the S&P 500 is sitting at all-time highs. I, for sure, thought that there was going to be a correction sometime in May. The way I am positioning myself is for a rally to start off June. I think that as long as the ECB does not...
by MaxGanik | Apr 29, 2014 | Blog, Finance & Economics
Posted April 29, 2014 9:45 Over the last few weeks we have seen quite a sell-off in the momentum names. However, the market did see a strong bounce over the last 2 weeks, up until Friday. I think that we are at the beginning of a two-month correction. Over the next...
by MaxGanik | Mar 30, 2014 | Blog, Finance & Economics
Posted March 30, 2014 20:16 Over the last few weeks, many of the high-flyers have fallen over 20%. All of these names are in the tech/biotech sector. More specifically, I am looking at buying some calls in IBB (the Biotech ETF) and NFLX. First the Biotechs: right now...